(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 15.88% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.15%.
Staar Surgical Co's revenue in 2025 is $224,449,000.On average, 3 Wall Street analysts forecast STAA's revenue for 2025 to be $12,806,635,025, with the lowest STAA revenue forecast at $12,574,082,631, and the highest STAA revenue forecast at $13,090,920,786. On average, 1 Wall Street analysts forecast STAA's revenue for 2026 to be $16,752,394,542, with the lowest STAA revenue forecast at $16,752,394,542, and the highest STAA revenue forecast at $16,752,394,542.
In 2027, STAA is forecast to generate $16,306,912,758 in revenue, with the lowest revenue forecast at $15,651,821,635 and the highest revenue forecast at $16,962,003,881.